These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Decision of the Department of Drugs of the National Board of Health and Welfare: indications for the use of clofibrate will be limited]. Strandberg K Lakartidningen; 1979 May; 76(18):1718-9. PubMed ID: 449462 [No Abstract] [Full Text] [Related]
10. Clofibrate and niacin in coronary heart disease. JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963 [No Abstract] [Full Text] [Related]
11. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. Br Heart J; 1978 Oct; 40(10):1069-118. PubMed ID: 361054 [No Abstract] [Full Text] [Related]
18. Serious adverse effects with clofibrate. N Z Med J; 1980 Oct; 92(670):315-6. PubMed ID: 6934431 [No Abstract] [Full Text] [Related]
19. Clofibrate and the primary prevention of ischaemic heart disease. Br Med J; 1978 Dec; 2(6152):1585-6. PubMed ID: 728731 [No Abstract] [Full Text] [Related]
20. [Study of clofibrate. The opinion of Prof. D. Kritchevsky]. Fabbrocini V Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692 [No Abstract] [Full Text] [Related] [Next] [New Search]